Castleview Partners, LLC Prokidney Corp Ord Shs Cl A(Cy Transaction History
Castleview Partners, LLC
- $151 Million
- Q4 2024
A detailed history of Castleview Partners, LLC transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Castleview Partners, LLC holds 29,900 shares of PROK stock, worth $49,634. This represents 0.03% of its overall portfolio holdings.
Number of Shares
29,900
Previous 32,921
9.18%
Holding current value
$49,634
Previous $55,000
9.09%
% of portfolio
0.03%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding PROK
# of Institutions
78Shares Held
46.7MCall Options Held
505KPut Options Held
127K-
Morgan Stanley New York, NY14.3MShares$23.7 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY12.3MShares$20.5 Million0.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.22MShares$8.66 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$6.07 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.2MShares$3.66 Million0.0% of portfolio
About PROKIDNEY CORP ORD SHS CL A(CY
- Ticker PROK
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,540,200
- Market Cap $102M